Related Experiment Videos
Hendrik Heers1, Martin Boegemann2, Axel Hegele1
1Department of Urology und Pediatric Urology, Philipps University Marburg.
Aktuelle Urologie
|February 2, 2018
Summary
2017 brought promising innovations in uro-oncology, particularly immunotherapy. This review covers advancements in diagnosing and treating prostate, bladder, and kidney cancers, with new drugs expected soon.
Area of Science:
- Uro-oncology
- Medical innovations
- Cancer research
Context:
- 2017 saw significant advancements in uro-oncology.
- Immunotherapy was a major focus in scientific discussions.
- The review covers prostate, bladder, and kidney cancers.
Purpose:
- To summarize recent therapeutic innovations in uro-oncology.
- To discuss future developments in cancer diagnosis and treatment.
- To highlight progress in treating specific metastatic cancers.
Summary:
- Major developments occurred in treating hormone-sensitive metastatic prostate cancer.
- Advancements were made in metastatic transitional cell carcinoma treatment.
- Progress in metastatic renal cell cancer treatment is noted.
- Numerous new therapeutic agents are anticipated.
Impact:
- Provides an overview of the latest uro-oncology news.
- Informs about upcoming therapeutic options.
- Aids clinicians in understanding recent treatment shifts.